Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 3
  • 5
  • 1
  • 5

Found 5 Coronary Artery Disease trials

A listing of Coronary Artery Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Digital Data and Heart Health | Using Digital Data to Predict Heart Disease
30 years - 74 years
All genders
Observational
What is the purpose of this study?   This research study is exploring about how digital data (ie. social media, online searches, and step tracking data) are associated with Coronary Heart Disease (CHD) and related risk factors in order to develop a more precise CHD risk predictor tool.   We …
45 years - 89 years
All genders
Interventional
This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a CADs system within the routine clinical practice of Canadian healthcare institutions.The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher …
 Study of Flurpiridaz (18F) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery Disease.
18 years - 99 years
All genders
Phase 3
This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD. Five hundred and fifty-two (552) evaluable subjects will be enrolled in this study, and will undergo SPECT MPI and Flurpiridaz (18F) Injection PET MPI, …
 Disrupt CAD III With the Shockwave Coronary IVL System
18 years - 99 years
All genders
The study design is a prospective, multicenter, single-arm, global IDE study to evaluate the safety and effectiveness of the Shockwave Medical Coronary Intravascular Lithotripsy (IVL) System in de novo, calcified, stenotic coronary arteries prior to stenting. Disrupt CAD III is being conducted as a staged pivotal study.
99 years or below
All genders
Phase 2
Interventional
The main purpose of this study is to evaluate the efficacy and safety of the investigational drug iptacopan (LNP023) in people with primary ITP or primary CAD. You will be in the study about 6 months with the opportunity to extend the total duration to about 31 months if you …